These findings suggest that the modification of transcription factors including C/EBPβ by epigenetic factors plays a critical role in muscle wasting, and the prevention of the p38-mediated activation of p300 could be a strategy to treat cachexia. The gene discussed is CEBPB; the disease is Cachexia.